Beloorbayir

Bengaluru, India Founded: 1981 • Age: 45 yrs Minicorn
Active pharmaceutical ingredients and nutraceuticals are manufactured and marketed.

About Beloorbayir

Beloorbayir is a Healthcare company based in Bengaluru (India) founded in 1981. Active pharmaceutical ingredients and nutraceuticals are manufactured and marketed. The company has 106 employees. Beloorbayir was last valued at $15.59 million in October 2016. Beloorbayir offers products and services including Active Pharmaceutical Ingredients, Botanical Extracts, Ayurvedic Products, and Medical Marijuana Extract. Its focus areas include Biopharma Outsourcing, CDMO, Small Molecules & Peptides and API Production. Its legal entity is Bayir Inc. Its competitors include Laurus Labs, Symbiotec and SeQuent; 2 of its 3 listed competitors have raised funding.

Company details

Managed company engaged in the manufacturing and marketing of select active pharmaceutical ingredients and nutraceuticals. It offers a broad portfolio of APIs and focuses on natural and nature-similar medicines, including botanical extracts sourced from wild and cultivated pesticide-free plants. The company has a strong emphasis on research and development, with a DSIR-recognized RD lab working on therapeutic areas such as neuroscience, pain management, anti-infectives, vital organ functioning, and cardiovascular diseases.

Key Metrics
  • Annual Revenue
    $9.08 M (USD)
    -4
    as on Mar 31, 2021
  • Net Profit
    -$206.74 K (USD)
    -19
    as on Mar 31, 2021
  • EBITDA
    $1.02 M (USD)
    -7
    as on Mar 31, 2021
  • Latest Funding Round
    $2.45M (USD), Unspecified

    Oct 2016

  • Investors
  • Employee Count
    106

Products & Services of Beloorbayir

Beloorbayir offers a comprehensive portfolio of products and services, including Active Pharmaceutical Ingredients, Botanical Extracts, Ayurvedic Products, and Medical Marijuana Extract.

Active Pharmaceutical Ingredients
Pharmaceuticals

Ingredients used for drug manufacturing and health applications.

Botanical Extracts
Nutraceuticals

Natural extracts for supplements and pharmaceutical uses.

Ayurvedic Products
Herbal Remedies

Traditional herbal products for health and wellness purposes.

Medical Marijuana Extract
Specialty Extracts

Extracts derived for therapeutic and medicinal applications.

Funding Insights of Beloorbayir

  • Total Rounds 2
  • Last Round Unspecified β€” $2.45M
  • First Round $12.27M

    (Mar 2014)

  • Investors Count 3

All 2 funding rounds of Beloorbayir with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.

DateAmountTransaction NameValuationLead InvestorsInvestors
Oct 2016$2.45MUnspecified$15.59MBritish International Investment
–
Mar 2014$12.27MUnspecified$15.82MRabo Equity Advisors, British International Investment
Valuation history
DateValuationStage
Oct 2016$15.59Mβ€’β€’β€’β€’β€’β€’β€’β€’
Mar 2014$15.82Mβ€’β€’β€’β€’β€’β€’β€’β€’

Last known valuation $15.59M (Oct 2016). 3 investors in total: 3 institutional.

Investors in Beloorbayir

Beloorbayir has secured backing from 3 investors, including venture fund and institutional investors. Prominent investors backing the company include British International Investment, Rabo Equity Advisors and Real Trust.

All
Venture Fund
Institutional
InvestorDescriptionFounded YearDomainLocation
Government agency focused on small and medium-sized businesses
1948bii.co.ukLondon, United Kingdom
Private equity firm focused on multiple sectors
Delhi, India
Manages diversified investment funds and portfolios for clients.
1972raboequity.comDelhi, India
Premium access

Investor details for Beloorbayir

The complete investor list, round-by-round participation and investor portfolios require an active premium plan.

  • Complete investor list
  • Round participation
  • Investor portfolios
  • Co-investor network

Verified entity values are shown only after access is granted.

Board of directors of Beloorbayir

The boards of the 2 registered companies of Beloorbayir currently have 5 directors; the longest-serving is Veena Beloor Ganapayya Bairy, appointed in 2004. 21 earlier directors have ceased.

DirectorDesignationAppointedTenureEntity
Veena Beloor Ganapayya Bairy
DIN 00452561
Director27 Feb 200422 yrs 8 moBayir Extracts Private Limited, Beloorbayir Biotech Limited
Beloor Ganapayya Bairy
DIN 00452458
Managing Director27 Feb 200422 yrs 8 moBayir Extracts Private Limited, Beloorbayir Biotech Limited
Ajay Ganapayya Bairy
DIN 00452362
Director22 Jan 201313 yrs 9 moBayir Extracts Private Limited, Beloorbayir Biotech Limited
Ashok Sinha
DIN 00299600
Director28 Mar 201511 yrs 7 moBeloorbayir Biotech Limited
Arvind Raghavan
DIN 05126971
Director28 Mar 201511 yrs 7 moBeloorbayir Biotech Limited

Financials of Beloorbayir

Figures of Bayir Extracts Private Limited, the primary company behind Beloorbayir, for FY 2021. Revenue was ₹4.85 Cr (+19% year on year). Net loss was -₹28.3 Lakh (-6% margin). EBITDA was ₹30 Lakh (6% margin). Revenue has grown at a compounded annual rate of -35% over three years and -19% over five years.

  • ₹4.85 CrRevenue · FY 2021 · +19% YoY
  • -₹28.3 LakhNet loss · -6% margin
  • ₹30 LakhEBITDA · 6% margin
  • ₹52 LakhPaid-up capital
  • 13Employees (provident fund records)
  • -35%Revenue CAGR, 3 years
  • -19%Revenue CAGR, 5 years

Balance sheet, profit and loss, cash flow and ratios of Bayir Extracts Private Limited are on its company page.

Premium access

Detailed financial statements for Beloorbayir

Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.

  • Statement rows
  • Financial ratios
  • Five-year trends
  • Downloads

Verified entity values are shown only after access is granted.

Timeline of Beloorbayir

4 dated milestones of Beloorbayir across 35 years, from founding to its latest funding, stage changes and deals.

  1. Founded Beloorbayir is founded.
  2. Funding First funding round of $12.3M.
  3. Milestone Reaches Minicorn status.
  4. Funding Latest funding round, Unspecified, of $2.5M.

Competitors of Beloorbayir

Beloorbayir has 3 listed competitors in our database, 2 of them funded. They include Laurus Labs, Symbiotec and SeQuent.

Company NameDomainFoundedHQ LocationTotal fundingEmployeesDescription
lauruslabs.com2005Hyderabad, India$229.73M6,035
Pharmaceutical and biotechnology company
symbiotec.in2002Indore, India$61.01M1,822
Non-sterile steroid hormone-based APIs and intermediates are manufactured.
sequent.in2002Bengaluru, India
APIs are developed and manufactured for therapeutic areas.
Premium access

Detailed competitors of Beloorbayir

The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.

  • Full competitor set
  • Operating metrics
  • Benchmarks
  • Competitive positioning

Verified entity values are shown only after access is granted.

Top companies in Biopharma Outsourcing & Drug Delivery

3 companies that operate in the same segment as Beloorbayir (Biopharma Outsourcing & Drug Delivery) in India, ranked by their profile score on The Company Check.

CompanyDescriptionFoundedLocationTotal fundingRevenueEmployees
Developer of integrated contract research development and manufacturing services
2007Bengaluru, Karnataka, IndiaUSD 35.74 MUSD 226.38 M2,062
Pharmaceutical and biotechnology company
2005Hyderabad, Telangana, IndiaUSD 229.73 MUSD 726.15 M548
India's leading healthcare products distribution platform
2018Mumbai, Maharashtra, IndiaUSD 59.67 MUSD 702.49 M557
Upgrade to premium

Unlock complete access to The Company Check

Get unrestricted viewing across everything we track β€” from companies and brands to investors, funding rounds, acquisitions, financials, and more.

Upgrade to Premium No viewing limits. Your plan controls exports and screening usage.
Included in your Premium account
  • βœ“
    Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
  • βœ“
    Full access to every database India & global coverage, advanced filters and rich profile details
  • βœ“
    Always-on access from your team account Single premium plan for everything you see on the portal

Frequently Asked Questions about Beloorbayir

Beloorbayir was founded in 1981 and raised its 1st funding round 33 years after it was founded.

Beloorbayir is headquartered in Bengaluru, India. It is registered at Bengaluru, Karnataka, India.

Beloorbayir has 106 employees.

Annual revenue of Beloorbayir is $9.08M as on Mar 31, 2021.

Managed company engaged in the manufacturing and marketing of select active pharmaceutical ingredients and nutraceuticals. It offers a broad portfolio of APIs and focuses on natural and nature-similar medicines, including botanical extracts sourced from wild and cultivated pesticide-free plants. The company has a strong emphasis on research and development, with a DSIR-recognized RD lab working on therapeutic areas such as neuroscience, pain management, anti-infectives, vital organ functioning, and cardiovascular diseases.

Beloorbayir's top competitors include Laurus Labs, Symbiotec and SeQuent.

Beloorbayir offers Active Pharmaceutical Ingredients, Botanical Extracts, Ayurvedic Products, and Medical Marijuana Extract.

Beloorbayir has 3 investors. Key investors include British International Investment, Rabo Equity Advisors, and Real Trust.

The valuation of Beloorbayir is $15.59M as of Oct 2016.

Beloorbayir is associated with 2 legal entities: Bayir Extracts Private Limited, Beloorbayir Biotech Limited.

The legal entities of Beloorbayir currently have 5 directors, including Veena Beloor Ganapayya Bairy, Ajay Ganapayya Bairy, Beloor Ganapayya Bairy and others.

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available